Cargando…

Effectiveness of treatment with nebulized colistin in patients with COPD

OBJECTIVES: To analyze whether the introduction of nebulized colistin in patients with chronic obstructive pulmonary disease (COPD) and infection with Pseudomonas aeruginosa (PA) is associated with a decrease of the number and duration of severe exacerbations. MATERIALS AND METHODS: Thirty six patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bruguera-Avila, Nuria, Marin, Alicia, Garcia-Olive, Ignasi, Radua, Joaquim, Prat, Cristina, Gil, Montserrat, Ruiz-Manzano, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634377/ https://www.ncbi.nlm.nih.gov/pubmed/29042767 http://dx.doi.org/10.2147/COPD.S138428

Ejemplares similares

Association between Air Pollution and Hemoptysis
por: Garcia-Olive, Ignasi, et al.
Publicado: (2016)

Comparison of Intravenous Ampicillin–sulbactam Plus Nebulized Colistin with Intravenous Colistin Plus Nebulized Colistin in Treatment of Ventilator Associated Pneumonia Caused by Multi Drug Resistant Acinetobacter Baumannii: Randomized Open Label Trial
por: Pourheidar, Elham, et al.
Publicado: (2019)

2231. Safety of Nebulized Colistin as Adjunctive Treatment of Lower Respiratory Tract Infections
por: Nadeem, Komal, et al.
Publicado: (2019)

Is nebulized saline a placebo in COPD?
por: Khan, Shahina Y, et al.
Publicado: (2004)

Health resource utilization for inpatients with COPD treated with nebulized arformoterol or nebulized formoterol
por: Ganapathy, Vaidyanathan, et al.
Publicado: (2017)

D-dimer in patients infected with COVID-19 and suspected pulmonary embolism
por: Garcia-Olivé, Ignasi, et al.
Publicado: (2020)

Evaluation of Interferon-Gamma Release Assays in the Diagnosis of Recent Tuberculosis Infection in Health Care Workers
por: Casas, Irma, et al.
Publicado: (2009)

Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives
por: Zhu, Yinggang, et al.
Publicado: (2021)

Nebulized Colistin And Continuous Cyclic Azithromycin In Severe COPD Patients With Chronic Bronchial Infection Due To Pseudomonas aeruginosa: A Retrospective Cohort Study
por: Montón, Concepción, et al.
Publicado: (2019)

Nebulized corticosteroids in the management of acute exacerbation of COPD
por: Gaude, G. S., et al.
Publicado: (2010)

A review of nebulized drug delivery in COPD
por: Tashkin, Donald P
Publicado: (2016)

Nebulized Therapies in COPD: Past, Present, and the Future
por: Barjaktarevic, Igor Z, et al.
Publicado: (2020)

Colistin dry powder inhalation with the Twincer™: An effective and more patient friendly alternative to nebulization
por: Akkerman-Nijland, A. M., et al.
Publicado: (2020)

Size Distribution of Colistin Delivery by Different Type Nebulizers and Concentrations During Mechanical Ventilation
por: Liu, Ching-Yi, et al.
Publicado: (2019)

Efficacy of Nebulized Glycopyrrolate on Lung Hyperinflation in Patients with COPD
por: Siler, Thomas M., et al.
Publicado: (2021)

Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPD
por: Donohue, James F, et al.
Publicado: (2019)

Nebulized formoterol: a review of clinical efficacy and safety in COPD
por: Gross, Nicholas J, et al.
Publicado: (2010)

Maintenance Therapy with Nebulizers in Patients with Stable COPD: Need for Reevaluation
por: Terry, Paul D., et al.
Publicado: (2020)

Perceptions and Attitudes of Patients and Their Family Caregivers on Nebulization Therapy for COPD
por: Dumra, Harjit, et al.
Publicado: (2022)

Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
por: Rouby, J. J., et al.
Publicado: (2020)

Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD
por: Bollu, Vamsi, et al.
Publicado: (2013)

Correction to: Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
por: Rouby, J. J., et al.
Publicado: (2020)

Impact of baseline clinical features on outcomes of nebulized glycopyrrolate therapy in COPD
por: Tashkin, Donald P., et al.
Publicado: (2021)

Randomized Control Study of Nebulized Colistin as an Adjunctive Therapy in Ventilator-Associated Pneumonia in Pediatric Postoperative Cardiac Surgical Population
por: Bharathi, K. S., et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on lung cancer diagnosis and treatment()
por: Serra Mitjà, Pere, et al.
Publicado: (2022)

Nebulized colistin for treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: we still need to straighten out the dose!
por: Honore, Patrick M., et al.
Publicado: (2015)

Effect of SGRQ-Defined Chronic Bronchitis at Baseline on Treatment Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate
por: Tashkin, Donald P, et al.
Publicado: (2021)

Effect of Nebulized Colistin on the Ventilator Circuit: a Prospective Pilot Case- Control Study from a Single Cancer Center
por: Ghonimat, Iyad M, et al.
Publicado: (2015)

Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features
por: De Pascale, Gennaro, et al.
Publicado: (2023)

MDI or nebulization in moderate to severe COVID-19 disease with COPD: which one is better?
por: Chilkoti, Geetanjali T., et al.
Publicado: (2021)

No Effects of Meteorological Factors on the SARS-CoV-2 Infection Fatality Rate
por: SOLANES, Aleix, et al.
Publicado: (2021)

Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate
por: Ohar, Jill A, et al.
Publicado: (2020)

Effectivness of Nebulized Budesonide for COPD Exacerbation Management in Emergency Department; a Randomized Clinical Trial
por: Aghili, Mehrad, et al.
Publicado: (2020)

Impact of Comorbidity Prevalence and Cardiovascular Disease Status on the Efficacy and Safety of Nebulized Glycopyrrolate in Patients with COPD
por: Putcha, Nirupama, et al.
Publicado: (2021)

Colistin Resistance in Aeromonas spp.
por: Gonzalez-Avila, Luis Uriel, et al.
Publicado: (2021)

High-Dose Nebulized Colistin Methanesulfonate and the Role in Hospital-Acquired Pneumonia Caused by Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Review
por: Karaiskos, Ilias, et al.
Publicado: (2023)

Bacterial Surface Detachment during Nebulization with Contaminated Reusable Home Nebulizers
por: Harris, Jamie C., et al.
Publicado: (2022)

Nebulized fentanyl for refractory dyspnea secondary to chronic obstructive pulmonary disease (COPD): A case report
por: Hildreth, Leah, et al.
Publicado: (2020)

Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate [Corrigendum]
Publicado: (2021)

Patient and social factors related to nebulizer use in COPD patients at the transition of care: a qualitative study
por: Foster, Amanda A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_424fopllnsrgr80g2du67088sf